On July 11, 2017, policymakers, donors, and advocates from around the world gathered at the Family Planning Summit in London, UK, to discuss efforts to reach our Family Planning 2020 goals and ensure that more women and girls around the world are able to plan their families and their futures. Watch highlights from this landmark event here.
The 51 contraceptive products, including the controversial Implanon and Implanon NXT, that were covered by the temporary restraining order (TRO) of the Supreme Court, have been determined to be non-abortifacient, or cannot cause abortion, by the Food and Drug Administration (FDA).
In Advisory No. 2017-302 dated Nov. 11, 2017, the FDA said it has already concluded the re-evaluation of the 51 contraceptive products.
“Per the FDA Resolutions dated 10 November 2017 (on the applications for recertification filed by the Market Authorization Holders [MAHs] with opposition filed by Alliance for the Family Foundation, Philippines, Inc. [ALFI]), the foregoing contraceptive products have been determined to be NON-ABORTIFACIENT,” the FDA said in its advisory.
The Food and Drug Administration (FDA) has certified that contraceptive implant brands Implanon and Implanon NXT are non-abortifacients or do not cause abortion.
The FDA on Sunday, November 12, released the results of its re-certification process of all 51 contraceptives covered by the two-year-old temporary restraining order (TRO) issued by the Supreme Court (SC) against the Reproductive Health (RH) Law. The document was dated Friday, November 10.
“Per the FDA’s Resolutions dated 10 November 2017 (on the applications for recertification filed by the Market Authorization Holders [MAHs] with opposition filed by Alliance for the Family Foundation, Philippines, Inc. [ALFI]), the foregoing contraceptive products have been determined to be non-abortifacient,” the FDA advisory read.
The resolution of the FDA, which began its review process in late August, signals the imminent lifting of the SC TRO. This is because the High Court had ruled in 2015 that the TRO would be deemed lifted if, after compliance with due process, the “questioned drugs and devices are found not abortifacient” by the FDA.
The Food and Drug Administration (FDA) on Sunday released a list of 51 contraceptives which will be re-certified as safe and non-abortifacient, paving the way for the implementation of one of the key measures of the Reproductive Health Law.
This effectively lifts the temporary restraining order issued by the Supreme Court in 2015, and allows the Health Department to distribute over 200,000 implants in their inventory before they expire in September next year.
“Per the FDA’s Resolutions dated 10 November 2017, the foregoing contraceptive products have been determined to be non-abortifacient,” the FDA said in its advisory.
Included in the list are implants like Implanon and Implanon NXT; injectables like Protec, intrauterine devices Mirena and Securit-T; and pills or oral contraceptives like Estrelle, Daphne, Yasmin, and Nordette, among others.
Vice President Jusuf Kalla held bilateral meeting with Nigerian counterpart Yemi Osinbajo here on Tuesday to discuss bilateral issues.
The meeting was held behind closed door close on cooperation in investment and family planning program.
Jusuf Kalla was accompanied by Foreign Minister Retno Marsudi, Minister of National Development Planning/head of the National Development Planning Board (Bappenas) Bambang Brodjonegoro and Industry Minister Enggartiasto Lukita.
“The Nigerian Vice President came to discuss a lot of issues such as investment and family planning,” Jusuf Kalla said after the meeting at VIP waiting room of the Halim Perdanakusuma airport, East Jakarta.
DKT Nigeria is helping to transform access to long-acting reversible contraception (LARC), IUDs and Implants. Almost all clinicians provide oral contraceptives and condoms, but fewer offer IUDs or implants. To overcome this gap, we are offering training & supportive supervision interventions on IUDs designed to increase health providers knowledge and counseling skills of LARC methods in Nigeria.
DKT Nigeria developed a training curriculum that gives doctors and nurses the skills to educate young women and couples about LARCs. The training includes a classroom session followed by a practical hospital-based session for insertion of IUDs conducted by our experienced trainers. After the training, each trainee undergoes intensive supportive supervision from our in-house clinical team and help providers to integrate IUDs and implants into routine contraceptive care by improving method specific knowledge and counseling and placement skills.
In the pilot phase, DKT trained 50 providers in Lagos with training and supportive supervision. In next 18 months, DKT aims to train 1000 doctors and nurses across Nigeria to improve access to LARC methods.
If you are a healthcare provider and interested, please send us an email to firstname.lastname@example.org or call 0812 991 7857 to register for the training program.
We are writing to share our initial research findings and recommendations on early implications of the US government’s ‘Protecting Life in Global Health Assistance’ policy [hereinafter ‘the policy’]. This research included interviews with representatives of 45 organizations in Kenya and Uganda that currently receive US global health funding, many of whom had planned to apply for renewals or new funds in the coming year. These organizations provide health services or conduct health advocacy and range from small community-based organizations to large nongovernmental organizations (NGOs) that work in many different countries. We have been in touch with USAID during this process and have incorporated information provided by USAID in an October 11, 2017 letter responding to our research queries.
As you know, over many decades, the US government has made deep and long-term investments in Kenya and Uganda that have saved lives and contributed to important health gains. However, both countries still confront high incidence of HIV/AIDS and poor reproductive health indicators including high rates of preventable maternal deaths.
We have outlined our key findings below on how early impact of the policy is already beginning to undermine local health systems and health gains and have attached a detailed summary of our research for your consideration ahead of the six-month review of the policy scheduled for November.
Reflections from Ejike Orji, CSO Focal point; Eva Ros, Director of Country Support, FP2020; and Adebimpe Adebiyi, Director of Family Health Department, Nigeria Ministry of Health on Nigeria’s commitments to family planning at the 2017 Reference Group meeting in Abuja, Nigeria.
The Vice President, Professor Yemi Osinbajo, says the Federal Government will continue to support the legacy of Babatunde Osotimehin, who was a strong advocate for public health and the rights of women and girls.
Professor Osinbajo stated this when he met with a delegation from the Family Planning (FP) 2020 Reference Group who paid him a visit on Wednesday at the Presidential Villa in Abuja.
He also said through its initiatives, the Buhari administration would continue to create more awareness on proper family planning in the country.
The Costed Implementation Plan (CIP) of the Population Welfare Department (PWD), in collaboration with the Health Policy Plus (HP+) project, conducted a training of trainers on male engagement in family planning from 9 to 11 October.
The CIP and PWD signed Memoranda of Understanding (MoU) with all the NGOs and CBOs who participated in the workshop to implement this training in their own union councils.
The Minister for Population Welfare Mir Mumtaz Hussan Jakhrani, Secretary, Population Welfare Department, Laeeq Ahmed, Technical Advisor, Costed Implementation Plan, Dr Talib Lashari, and other senior members of the Population Welfare Department and HP+ were present at the signing ceremony.